This contract involves the supply, installation, and commissioning of a formulation and filling equipment designed to mix cellular products uniformly for the final CART product formulation. This equipment will be used by the Immunology Service (Immunotherapy Section) at the Hospital Clínico de Barce
Tender closed on 13 Mar 2026. Awaiting award.
The Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of Prosigna reagents. These reagents are essential for analyzing the PAM50 gene expression signature, which has prognostic value in the management of breast cancer. This opportunity is aimed at suppliers who can deliver hi
The Consorci Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of various exclusive pharmaceuticals from Merck Europe B.V. This contract, valued at approximately €3,988,817.08, aims to enhance the healthcare services provided by the hospital. Interested suppliers should refer
The Consorci Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of implantable defibrillators and electrodes. This contract is aimed at enhancing cardiac care at the Instituto Clínico Cardiovascular within the Hospital Clínic de Barcelona. The total value of the contract is ap
This contract involves the supply of drainage, aspiration, and irrigation systems for the Hospital Clínic de Barcelona. The total value of the contract is approximately €542,967.38. Suppliers are invited to provide these medical systems to support healthcare services at the hospital. For more detail
UK-based astronomy observers can apply for travel and subsistence grants of up to £15,000 over two years to visit facilities with competitively awarded observation time.
UK biomedical researchers can apply for up to £1 million in MRC funding to purchase a single piece of mid-range capital equipment by 31 December 2027.
NERC invites qualified researchers to apply for large grants (£1.12-£3.45 million) for innovative environmental science projects lasting up to five years.
UKRI is offering up to £60 million over seven years for a director-led research institute to investigate obesity and cardiometabolic disease mechanisms with translation to prevention and treatment strategies.
